Prosecution Insights
Last updated: April 19, 2026

Ractigen Therapeutics

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17419569 OLIGOMERIC NUCLEIC ACID MOLECULE AND APPLICATION THEREOF TRAN, CHRISTINA L 1637 Non-Final OA Jun 29, 2021

Managing Ractigen Therapeutics's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month